
CONSORT Extension for Reporting N-of-1 Trials for Traditional Chinese Medicine
(CENT for TCM 2019)
​Overview
​
The CONSORT Extension for Reporting N-of-1 Trials for Traditional Chinese Medicine (CENT for TCM) provides evidence-based recommendations for reporting N-of-1 trials evaluating traditional Chinese medicine (TCM) interventions. Developed through an international consensus process, the guideline extends the original CENT Statement by incorporating reporting items that address the unique characteristics of TCM theory, diagnosis and treatment.​
​
What is it for?​
​
CENT for TCM provides a structured reporting framework to help authors clearly describe the design, conduct, interventions and findings of N-of-1 trials involving traditional Chinese medicine. The guideline aims to improve reporting quality, transparency and reproducibility while ensuring TCM-specific information is adequately documented.​
​
Who should use it?​
​
Researchers, clinicians, students, journal editors, peer reviewers and others involved in the design, conduct, reporting and evaluation of N-of-1 trials investigating traditional Chinese medicine interventions.​
​
Key resources​
​
The CENT for TCM guideline includes a reporting checklist that extends the original CENT Statement with recommendations specific to traditional Chinese medicine, together with an accompanying Explanation and Elaboration paper.
​
​​
​
​
​
​
​​
​
​
​
​
​
​
​​
About CENT for TCM
​
Type
Reporting guideline
Published
2019
Developed by
CENT for TCM Group
Based on
International expert consensus
Number of items
25
Full references
​
Li, J., Hu, J. Y., Zhai, J. B., Niu, J. Q., Kwong, J. S., Ge, L., ... & CENT for TCM Working Group. (2019). CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM): Recommendations, explanation and elaboration. Complementary Therapies in Medicine, 46, 180-188.​​
​
Related Guidelines
​

